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Abstract
Background: The pathogenicity of staphylococcus aureus is dependent largely upon its ability to secrete a number of
virulence factors, therefore, anti-virulence strategy to combat S. aureus-mediated infections is now gaining great interest. It
is widely recognized that some plant essential oils could affect the production of staphylococcal exotoxins when used at
subinhibitory concentrations. Perilla [Perilla frutescens (L.) Britton], a natural medicine found in eastern Asia, is primarily used
as both a medicinal and culinary herb. Its essential oil (perilla oil) has been previously demonstrated to be active against S.
aureus. However, there are no data on the influence of perilla oil on the production of S. aureus exotoxins.
Methodology/Principal Findings: A broth microdilution method was used to determine the minimum inhibitory
concentrations (MICs) of perilla oil against S. aureus strains. Hemolysis, tumour necrosis factor (TNF) release, Western blot,
and real-time RT-PCR assays were performed to evaluate the effects of subinhibitory concentrations of perilla oil on
exotoxins production in S. aureus. The data presented here show that perilla oil dose-dependently decreased the production
of a-toxin, enterotoxins A and B (the major staphylococcal enterotoxins), and toxic shock syndrome toxin 1 (TSST-1) in both
methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA).
Conclusions/Significance: The production of a-toxin, SEA, SEB, and TSST-1 in S. aureus was decreased by perilla oil. These
data suggest that perilla oil may be useful for the treatment of S. aureus infections when used in combination with b-lactam
antibiotics, which can increase exotoxins production by S. aureus at subinhibitory concentrations. Furthermore, perilla oil
could be rationally applied in food systems as a novel food preservative both to inhibit the growth of S. aureus and to
repress the production of exotoxins, particularly staphylococcal enterotoxins.
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Introduction
Staphylococcus aureus is a gram-positive pathogen that causes an
array of diseases, ranging from minor localized skin lesions to life-
threatening deep tissue damage and systemic infections such as
pneumonia, endocarditis, and exotoxin syndromes [1]. Addition-
ally, S. aureus is an important food-borne pathogen that causes
staphylococcal gastroenteritis and food poisoning in humans [2]. S.
aureus has the potential to produce a large number of secreted and
cell wall-related virulence factors that contribute to the diversity of
S. aureus-associated illnesses [3].
a-toxin, enterotoxins, and toxic shock syndrome toxin 1 (TSST-
1) are among the major exotoxins secreted by S. aureus. a-toxin is a
33 kDa pore-forming extracellular protein that is secreted by most
S. aureus strains and has hemolytic, cytotoxic, dermonecrotic and
toxic properties. Penetration of host cell membranes by a-toxin
leads to the formation of a hexameric transmembrane pore that
causes cell lysis [4]. Many human cells, including erythrocytes,
monocytes, lymphocytes, macrophages and epithelial cells, are
affected by a-toxin. Staphylococcal enterotoxins (SEs) and TSST-
1 are intermediate molecular weight proteins (20–30 kDa) that
cause food poisoning and toxic syndrome, respectively, in humans
and other species [5]. Moreover, both SEs and TSST-1 can act as
bacterial superantigens that bind to MHC class II molecules on
antigen presenting cells and selectively stimulate T cells expressing
appropriate Vb gene segments on their T cell receptors (TCRs)
[6]. The secretion of staphylococcal exotoxins is regulated in a
growth-phase-dependent manner, predominantly occurring dur-
ing the post-exponential phase [7]. The accessory gene regulator
(agr) locus, a well-characterized two-component regulatory system,
plays a critical role in the regulation of exotoxin production by S.
aureus [3].
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difficult to treat S. aureus infections. Therefore, both in the food and
pharmaceutical industries, there is a continuous need to develop new
therapeutics to aid in the prevention and treatment of lethal infections
caused by these strains. Recently, much research has focused on plant
extracts, in particular essential oils, due to their potent antimicrobial
properties against a broad spectrum of microorganisms [4].
Perilla [Perilla frutescens (L.) Britton], a natural medicine found in
eastern Asia, is primarily used as both a medicinal and culinary herb
[8]. Its essential oil (perilla oil), which contains a high amount of a-
linolenic acid (ALA), has been shown to possess a variety of medicinal
properties, including antitumor, antioxidative, antimicrobial, anti-
inflammatory, and anti-anaphylactic shock activities [9–13]. Fur-
thermore, nutritional studies have shown that perilla oil is beneficial
for healthy aging and learning performance [14,15]. The objective of
this study was to assess the anti-S. aureus activity of perilla oil and to
further investigate the influence of subinhibitory concentrations of
perilla oil on the production of a-toxin, the two major enterotoxins
(SEA and SEB), and TSST-1 in both methicillin-sensitive S. aureus
(MSSA) and methicillin-resistant S. aureus (MRSA).
Results
Impact of perilla oil on S. aureus growth
In this study, perilla oil exhibited a significant antibacterial
activity against the test strains, with MIC values of 0.2–0.8 ml/ml.
The MIC values of perilla oil against S. aureus strains ATCC
29213, MRSA 2985 and MRSA 3701, which were selected for
further experiments, were all 0.4 ml/ml.
Prior to evaluating the influence of subinhibitory concentrations
of perilla oil on the production of bacterial virulence factors, we first
investigated the effect of increasing concentrations of perilla oil on
the growth of S. aureus. As shown in Fig. 1A, perilla oil, at
concentrations ranging from 1/16 to 1/26MIC, had no significant
influence on the growth of S. aureus strain ATCC 29213. However,
treatment with MIC of perilla oil could inhibit the growth rate; after
60, 210 and 420 min of perilla oil treatment, the OD600 nm values
were 62.1%, 45.6% and 63.6% of the perilla oil-free culture,
respectively. Notably, when cultured with 26MIC of perilla oil, the
growth of S. aureus was completely inhibited. Although the growth
kinetics can vary greatly between strains, the growth of MRSA 2985
and MRSA 3701 were affected in a similar manner by these
concentrations of perilla oil. In other words, supplementation with
1/16, 1/8, 1/4, and 1/26 MIC of perilla oil had no significant
effects on MRSA 2985 and MRSA 3701 growth (Fig. 1B & C.).
Moreover, the relationship between the OD values and colony-
forming units (CFUs) was determined by viable counts. The data
indicated that the levels of bacteria in the control culture and the
perilla oil-treated (1/16, 1/8, 1/4, and 1/26 MIC) cultures were
approximately 1.0610
9 CFU/mlwhen growntoan OD600 nmvalue
of 2.5. Furthermore, no morphological differences were observed
when S. aureus ATCC 29213 cultured with graded subinhibitory
concentrations of perilla oil to the post-exponential phase (Fig. S1).
Perilla oil decreases hemolytic and T-cell stimulating
activities of S. aureus culture supernatants
Hemolysins secreted by S. aureus can promote hemolysis of
rabbit erythrocytes, while other proteins secreted by the bacteria
can act as superantigens which stimulate T-cell proliferation.
Therefore, a hemolysis assay and a murine T-cell proliferation
assay were used to investigate the effect of perilla oil treatment on
the hemolytic and T-cell stimulating activities of S. aureus culture
supernatants.
As shown in Table 1, when supplemented with 1/166MIC of
perilla oil, the hemolytic activities of the culture supernatants of S.
aureus strains ATCC 29213, MRSA 2985 and MRSA 3701 were
82.1%, 48.3% and 77.8% of their drug-free culture, respectively.
Remarkably, no hemolytic activity was observed when cultures
were grown in the presence of 1/2 or 1/46 MIC of perilla oil.
This dose-dependent inhibition of hemolysis was observed in all of
Figure 1. Growth curves of S. aureus after exposure to various
concentrations of perilla oil. S. aureus strains ATCC 29213 (A), MRSA
2985 (B), and MRSA 3701 (C) were grown in the presence of increasing
concentrations of perilla oil at 37uC with agitation at 200 rpm under
aerobic conditions, and cell growth was monitored by measuring the
OD values at 600 nm at the indicated time points. These curves
represent one of three reproducible experiments.
doi:10.1371/journal.pone.0016160.g001
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induce or inhibit hemolysis of rabbit erythrocytes at 16MIC, and
there was little influence on the hemolytic activity of culture
supernatants when pre-incubated with 16MIC of perilla oil (data
not shown). Cells of S. aureus cultures in the presence of 1/26MIC
of perilla oil were collected and re-grown in fresh MHB to the
post-exponential phase. The hemolytic activity of the culture
supernatants was evaluated. The results indicated that the
inhibited hemolytic activity was reversible. Therefore, the
reduction is not likely to be due to the selection of mutants.
As shown in Fig. 2, the culture supernatants of S. aureus grown in the
presence of increasing concentrations of perilla oil showed a
significantly reduced stimulatory effect on T-cell proliferation.
Additionally, perilla oil itself did not stimulate or inhibit T-cell
activation at 16MIC. Perilla oil appeared to attenuate the T-cell-
activating activity of culture supernatants in a dose-dependent fashion.
Perilla oil decreases a-toxin, SEA, SEB, and TSST-1 levels in
S. aureus culture supernatants
The addition of 1/16, 1/8, and 1/46MIC of perilla oil has no
significant influence on S. aureus extracellular protein concentra-
tion. However, a slight decrease of protein secretion was observed
when cultured with 1/26MIC of perilla oil (Table 2).
Among the secreted proteins of S. aureus, a-toxin is the exotoxin
primarily responsible for the hemolytic activity of S. aureus culture
fluid, while SEs and TSST-1 are the most critical exotoxins that can
act as superantigens, stimulating T-cell-activation. Western blot
analysiswasperformedtodeterminewhetherthe reducedhemolytic
and T-cell stimulating activities of S. aureus culture supernatants
cultured in the presence of increasing concentrations of perilla oil
was due to the diminished production of a-toxin, SEA and SEB (the
major SEs), and TSST-1. As shown in Fig. 3, treatment with graded
subinhibitory concentrations of perilla oil resulted in a dose-
Table 1. Hemolytic activities of S. aureus culture supernatants treated with graded subinhibitory concentrations of perilla oil.
Strains Hemolysis (%) of rabbit erythrocytes by culture supernatant
a
0 1/166MIC 1/86MIC 1/46MIC 1/26MIC Re-grown cultures
c
ATCC 29213 100% 82.1%67.9 42.5%66.2
* NO
b NO. 94.3%66.6
MRSA 2985 100% 48.3%63.5
* 12.5%64.1
** NO. NO. 98.2%64.9
MRSA 3701 100% 77.8%66.8 54.1%65.2 29.1%63.9
** NO. 90.6%67.8
aThe drug-free culture supernatants served as the 100% hemolysis control.
bNO. signifies that there was no observed hemolytic activity.
cCells of S. aureus in the presence of 1/26MIC of perilla oil were harvested and re-grown in fresh MHB.
Values represent the mean and standard deviation of three independent experiments. * indicates p ,0.05 and ** indicates p,0.01, when compared to the
corresponding control.
doi:10.1371/journal.pone.0016160.t001
Figure 2. Induction of murine splenocyte proliferation by S. aureus supernatants. S. aureus strains were cultured with graded subinhibitory
concentrations of perilla oil in RPMI 1640. Values represent the mean 6 SD for three independent experiments. * represents p,0.05 and ** represents
p,0.01.
doi:10.1371/journal.pone.0016160.g002
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TSST-1. Growth with 1/166 MIC of perilla oil resulted in a
recognizable reduction in the secretion of these toxins; while at 1/2
or 1/46MIC, little to none of these immunoreactive proteins could
be detected in the culture fluids of any of the strains tested.
The proteolytic activity of the culture supernantants was
determined to confirm whether the reduction of toxins production
in S. aureus was due to the increase in protease secretion induced by
perilla oil. There was no significant influence on protease secretion
by ATCC 29213, MRSA 2985 or MRSA 3701 cultured with
subinhibitory concentrations of perilla oil (Fig. 4).
Perilla oil inhibits the transcription of hla, sea, seb, tst, and
agrA in S. aureus
Based on the finding that perilla oil significantly represses the
production of a-toxin, SEA and SEB, and TSST-1 in S. aureus,w e
Table 2. Protein contents in supernatants of S. aureus.
Strains Extracellular protein concentration (mg/ml) of S. aureus after treatment with perilla oil
a
0 1/166MIC 1/86MIC 1/46MIC 1/26MIC
ATCC 29213 7.52160.52 7.56260.46 7.38960.23 7.43560.44 6.00960.36
MRSA 2985 6.45360.38 6.27860.22 6.47760.35 6.19960.34 5.55460.28
MRSA 3701 5.79460.66 5.65160.41 5.46860.55 5.71260.37 4.81260.49
aMean values 6SD from three independent experiments.
doi:10.1371/journal.pone.0016160.t002
Figure 3. Western blot analysis of a-toxin, SEA, SEB, and TSST-1 production. S. aureus strains ATCC 29213 (A), MRSA 2985 (B) and MRSA
3701 (C) were grown in the presence or absence of increasing concentrations of perilla oil in MHB until the post-exponential growth phase. Equal
amount of extracellular proteins were subjected to western blot analysis. (D) Coomassie-stained SDS-PAGE of secreted proteins by S. aureus strain
ATCC 29213, arrows indicate the proteins that are not influenced by perilla oil.
doi:10.1371/journal.pone.0016160.g003
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expression levels of these toxin-encoding genes (hla, sea, seb, and tst,
respectively) after treatment with perilla oil. Additionally, because
the expression of these genes is positively regulated by the agr locus
[16], the transcription level of agrA was also detected. As expected,
the expression levels of these genes in S. aureus strain ATCC 29213
were markedly repressed upon treatment with perilla oil (Table 3).
When cultured with 1/26MIC of perilla oil, the expression levels
of hla, sea, seb, tst and agrA were decreased by 10.7-, 6.1-, 5.5-, 9.5-
and 6.4-fold, respectively.
Discussion
The emergence of multidrug-resistant strains of S. aureus
presents a threat to the worldwide population; therefore, there is
a continuing quest to discover new antimicrobial compounds from
unexplored sources [17]. Recently, plant extracts, and in
particular their essential oils, have garnered great interest for
their potent antimicrobial properties against a broad spectrum of
microorganisms [18]. In the last few years, numerous studies have
been conducted in different countries to demonstrate their
usefulness in therapeutic treatments [19,20]. Perilla [Perilla
frutescens (L.) Britton] is a medicinal and edible plant of the family
Labiatae. In indigenous medicine, perilla has long been used to
treat colds, headaches, and coughs. Its essential oil (perilla oil) has
been shown to possess a number of pharmacological activities [9–
13]. In this report, we confirmed that perilla oil was active against
both MSSA and MRSA with MICs ranging from 0.2–0.8 ml/ml.
Therefore, perilla oil may be useful as a potential antibacterial
agent to combat the pathogen, and it may deserve further
investigation for its potential therapeutic efficacy in S. aureus
infections.
The pathogenicity of S. aureus is dependent, to a great extent,
upon the secretion of a variety of extracellular virulence factors
[3]. Therefore, the clinical performance of antimicrobial agents
used for the treatment of S. aureus infections not only depends on
the respective bacteriostatic or bactericidal effects, but also on the
ability to prevent the release of virulence factors by dying or
stressed bacteria [7]. Additionally, an alternative therapeutic
strategy for S. aureus infections that is now gaining great interest is
the targeting of bacterial virulence, which provides promising
opportunities to abate pathogenicity and its consequences without
exerting immediate life-or-death pressure on the target pathogen
[21].
It has long been known that many antibiotics that exhibit little
or no influence on overall growth can affect the expression of S.
aureus virulence factors when used at sub-lethal concentrations.
The antibiotic-induced regulation of virulence factors may result
in either aggravation or attenuation of the infection. Therefore,
the potential of antibiotics to affect these properties may be an
important consideration when selecting an antibiotic for therapy.
For instance, protein-synthesis-inhibiting antibiotics such as
clindamycin, linezolid, and quinupristin/dalfopristin are recom-
mended for the treatment of S. aureus-induced toxic syndromes
because concentrations below the MIC have been shown to
decrease the production of exotoxins in S. aureus (including a-toxin,
SEA, SEB, TSST-1, and protein A) [7,22,23]. In contrast, b-
lactam antibiotics proved unfavorable for the management of
toxin-related S. aureus infections, as even subinhibitory concentra-
tions (for example of methicillin) promote an increase in a-toxin
and TSST-1 production via a stimulatory effect on exoprotein
synthesis [24]. In this report, through the use of transcriptional,
expressional and phenotypic analyses, we have shown that
subinhibitory concentrations of perilla oil dose-dependently
suppress a-toxin, SEA and SEB, and TSST-1 expression in both
MSSA and MRSA. These data suggest that perilla oil may be
useful for the treatment of S. aureus infections when used in
combination with b-lactam antibiotics, which can increase
exotoxin production by S. aureus at subinhibitory concentrations.
In food industry a negative consumer reaction to chemical
preservatives has prompted an increased interest in natural
alternatives [25]. For these reasons, plant essential oils, because
of their established antimicrobial activities as well as their relatively
lower toxicity and reduced number of side effects, may be
potentially useful replacements for chemical preservatives [18].
Because plant essential oils have a multi-component nature, it is
more difficult for bacteria to develop resistance than many
common used antibiotics, which have a single target site [26].
Additionally, staphylococcal food poisoning does not result from
the ingestion of S. aureus itself, but rather from ingestion of one or
more preformed staphylococcal enterotoxins in food that has been
contaminated with the bacteria [27]. Therefore, considering its
anti-S. aureus activity, as well as the findings that it significantly
decreases the production of SEA and SEB by S. aureus, perilla oil
Figure 4. Protease units of S. aureus culture supernatants.
Bacteria were cultured with increasing concentrations of perilla oil to
reach an OD600nm of 2.5. The culture supernatants were collected by
centrifugation, and used for proteolytic activity assay. Values represent
the mean 6 SD for three independent experiments.
doi:10.1371/journal.pone.0016160.g004
Table 3. Relative gene expression levels of hla, sea, seb, tst
and agrA in S. aureus ATCC 29213 after treatment with
0.2 mLm L
21 of perilla oil.
Gene Product Fold changes ± SD
a
hla a-toxin 210.762.7
sea Staphylococcal enterotoxin A 26.161.8
seb Staphylococcal enterotoxin B 25.561.5
tst Toxic shock syndrome toxin 1 29.562.4
agrA Accessory gene regulator A 26.462.0
aThe real-time RT-PCR results represent the mean of three biological replicates
with three technical replicates for each gene. SD indicates standard deviation.
doi:10.1371/journal.pone.0016160.t003
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growth of S. aureus and to suppress the expression of SEs.
In S. aureus, the production of virulence factors during the
growth cycle is controlled by global regulators such as agr and
SarA [16]. Previous studies have shown that subinhibitory
concentrations of antibiotics can affect the translation of certain
regulatory gene products in S. aureus, which, in turn, alter the
transcription of toxin-encoding genes. For instance, subinhibitory
concentrations of thymol decreased exotoxin production in S.
aureus, possibly in part due to inhibition of the agr locus [28].
Similarly, subinhibitory concentrations of clindamycin differen-
tially reduced the transcription of exoprotein genes in S. aureus,i n
part through modulation of the sar locus [22]. To address this, a
real-time RT-PCR assay was used to assess the impact of perilla oil
on the expression level of the agr locus in S. aureus, which is thought
to positively regulate a-toxin, SEA and SEB, and TSST-1
production [16]. The data indicated that the expression level of
agrA was significantly reduced when S. aureus strain ATCC 29213
was cultured with 1/26MIC of perilla oil. Nevertheless, with the
current data, it is unknown whether agr or other regulators are
involved. Therefore, we presume that the reduced production of
these toxins may, in part, depend on inhibition of the agr locus
induced by perilla oil.
Materials and Methods
Ethics Statement
All animal studies were conducted according to the experimen-
tal practices and standards approved by the Animal Welfare and
Research Ethics Committee at Jilin University (Approval ID:
20100305-2). The study was also approved by the Institutional
Review Board of the First Hospital of Jilin University, and all
patients provided written informed consent for the collection of
samples and subsequent analysis [29].
Bacterial strains and reagents
The methicillin-sensitive S. aureus strain ATCC 29213 was
obtained from American Type Culture Collection (ATCC).
Twenty-six S. aureus isolates (7 MSSA and 19 MRSA) were
acquired from clinical samples at the First Hospital of Jilin
University [29]; the clinical MRSA strains 2985 and 3701, which
have the potency to secrete a-toxin, SEA, SEB, and TSST-1, were
used for further experiments. Bacteria were stored as 30% glycerol
stocks at 280uC and subcultured on blood agar plates at 37uC
before testing. Perilla oil (pure essential oil) was extracted by water
distillation and supplied by the National Institute for the Control
of Pharmaceutical and Biological Products (Beijing, China).
MIC determination
The minimum inhibitory concentrations (MICs) of perilla oil
against S. aureus strains were determined using a broth microdilu-
tion method as described by Carson et al. [30] with minor
modifications. Stock solutions of perilla oil at various concentra-
tions were prepared in dimethyl sulfoxide (DMSO) (Sigma-
Aldrich, St. Louis, MO, USA). All tests were performed in
Mueller–Hinton broth (MHB) (BD Biosciences, Inc., MD, USA)
supplemented with Tween-80 (Sigma-Aldrich) at a final concen-
tration of 0.5%. Serial doubling dilutions of perilla oil were
prepared in a 96-well plate over the concentration range of 0.05–
3.2 ml/ml. Following inoculation of 5610
5 cfu/ml of overnight
broth cultures in each well, the plates were incubated aerobically
at 37uC for 24 h. The MIC was defined as the lowest
concentration of perilla oil at which the microorganism did not
demonstrate visible growth.
Growth curves and viable counts
Bacteria were grown in the presence of increasing concentra-
tions of perilla oil at 37uC with agitation at 200 rpm under aerobic
conditions, and cell growth was monitored by reading the OD
values at 600 nm at the indicated time points.
When the OD600 nm values were reached 2.5, serial 10-fold
dilutions of the samples were spread onto drug-free Mueller-
Hinton agar plates. The number of colonies was determined after
an incubation period of 24 h at 37uC.
Hemolysis assay
Total hemolysiswas determinedasdescribed previously [28] with
rabbit erythrocytes, which are 1000 times more sensitive to S. aureus
a-toxin than human erythrocytes. In brief, bacteria were grown in
MHB supplemented with 0.5% Tween-80 at 37uC with graded
subinhibitory concentrations of perilla oil until reaching the post-
exponential growth phase (OD600 nm of 2.5). Culture supernatants
were harvested and filter sterilized with a 0.22 mm pore-size acetate
syringe filter. A 0.1 ml volume of culture supernatant was combined
with 2.5% defibrinated rabbit blood in PBS buffer. After 15 min at
37uC, the unlysed blood cells were pelleted by centrifugation
(55006 g, room temperature, 1 min). The hemolytic activity was
determined by reading the optical density of the cell-free
supernatant at 543 nm. The control culture supernatant served as
the 100% hemolysis control, and relative percentage hemolysis
values were calculated by comparison to this value.
Bacteria were cultured with 1/26MIC of perilla oil to reach an
OD 600nm of 2.5. Cells were collected by centrifugation, and
washed three times in sterile PBS. Thereafter, bacteria were re-
grown in fresh MHB to the post-exponential phase. The culture
supernatants were collected and subjected to hemolysis assay as
described above.
Murine T-cell proliferation assay
The murine T-cell proliferation assay was performed according
to the method described previously by Qiu et al. [31]. Overnight
cultures of MSSA ATCC 29213, MRSA 2985, and MRSA 3701
in Roswell Park Memorial Institute Medium 1640 (RPMI 1640)
(Invitrogen, CA, USA) were diluted 30-fold in 500 ml of
prewarmed RPMI 1640 supplemented with 0.5% Tween-80;
these cultures were incubated for 30 min at 37uC with constant
shaking, and divided into 100 mL aliquots. Increasing concentra-
tions of perilla oil (1/16, 1/8, 1/4 and 1/26MIC) were added to
the diluted bacterial suspensions before incubation for a further
4 h. Perilla oil-untreated S. aureus supernatants served as controls.
Proteins secreted into the supernatants were filtered through a
0.2 mm pore-size filter and immediately analyzed as described
below.
Specific-pathogen-free BALB/c mice (male, 6- to 8-weeks-old,
weighing 18 to 22 g) were obtained from the Experimental Animal
Center of Jilin University (Changchun, China). Spleen cell
suspensions were prepared in RPMI 1640, washed and then
resuspended in complete medium (RPMI 1640 media supple-
mented with 10% fetal bovine serum, 2 mM glutamine, 100 IU/
ml penicillin, 100 IU/ml streptomycin, 15 mM HEPES and
50 mM 2-mercaptoethanol). A total of 10
6 (150 ml) cells were
dispensed into the wells of a 96-well tissue culture plate.
Cell proliferation was determined by the MTT assay. S. aureus
culture supernatants (50 ml) were added to the tissue culture plates
described above. After incubation at 37uC for 72 h with 5% CO2,
20 ml MTT (5 mg/ml) dissolved in PBS was added to each well,
and the plate was incubated for a further 4 h at 37uC. The cells
were collected by centrifugation for 10 min at 5006g. The pellet
was redissolved in 150 ml DMSO at room temperature for 10 min,
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microplate reader (TECAN, Austria). The splenocytes’ viability
and number are represented by OD 570 nm.
Determination of proteolytic activity and extracellular
protein concentration
Bacteria were grown in MHB supplemented with 0.5% Tween-
80 in the absence or presence of increasing concentrations of
perilla oil until reaching an OD600 nm of 2.5, the culture
supernatants were harvested by centrifugation.
For proteolytic activity assay, a 100 ml volume of supernatant was
added to 1 ml of azocasein (Sigma-Aldrich) and incubated at 37uC
for 1 h. Thereafter, 1 ml trichloroacetic acid (5%, w/v) was applied
to terminate the reaction; undigested azocasein was allowed to
precipitate for 30 min. The mixture was then centrifuged at
10,0006g for 10 min, and the absorbance of the supernatant was
read at 328 nm. One unit of protease activity was defined as giving
an absorbance of 0.001 after incubation for 1 h at 37uC.
The culture supernatants were precipitated by adding 100%
trichloroacetic acid (Sigma) to a final concentration of 10%. After
overnight incubation at 4uC, the precipitate was centrifuged at
15,0006g for 20 min at 4uC and finally washed three times with
ice-cold (220uC) ethanol. The aggregated proteins were dried by
using a Speed-Vac for a few minutes. The protein extracts were
dissolved in 0.5 ml of 0.1 M Tris.
The protein concentrations were determined with a Bio-Rad
(Munich, Germany) protein assay kit according to the instructions
of the manufacturer.
SDS-PAGE and western blot assay
Equal amount of protein was subjected to Sodium dodecyl
sulfate (SDS)-polyacrylamide (12%) gel electrophoresis run at
120 V. The gel was stained overnight in 0.1% Coomassie brilliant
blue R250 with 25% isopropanol and 10% acetic acid.
For western blot assay, proteins were transferred to polyvinyli-
dene fluoride membranes (Wako Pure Chemical Industries, Ltd,
Osaka, Japan) using a semi-dry transfer cell (Bio-Rad, Munich,
Germany). Membranes were incubated overnight at 4uCi n1 0 %
milk powder (a blocking reagent). The production of a-toxin, SEA,
SEB, and TSST-1 in S. aureus was detected by incubation with
indicated antibodies. Antibodies to a-toxin, SEA, and SEB were
purchased from Sigma-Aldrich and diluted to 1:10000, 1:5000 and
1:8000, respectively; a horseradish peroxidase-conjugated anti-
rabbit antiserum (Sigma-Aldrich) diluted to 1:4000 was then used as
the secondary antibody. The antibody to TSST-1 (Santa Cruz
Biotechnology, California, USA) was diluted to 1:200 according to
the manufacturer’s recommendation, and a horseradish peroxidase-
conjugated anti-mouse antiserum (Sigma-Aldrich) diluted to 1:5000
was used as the secondary antibody. The membrane was treated
with ECL substrate (GE Healthcare, Buckinghamshire, UK)
according to the manufacturer’s instructions, and exposed to x-
ray film.
RNA isolation and real-time RT-PCR
S. aureus strain ATCC 29213 was incubated with or without
0.2 ml/ml of perilla oil to the post-exponential growth phase
(OD600 nm of 2.5) as described in the hemolysis assay. Cells were
harvested by centrifugation (5,0006g for 5 min at 4uC) and
resuspended into TES buffer (10 mM Tris-Cl, 1 mM EDTA,
0.5% SDS) containing 100 mg/ml of lysostaphin (Sigma-Aldrich).
Following incubation at 37uC for 10 min, a Qiagen RNeasy Maxi
column was used to isolate total bacterial RNA, which was in
accordance with the manufacturer’s instructions. The contami-
nating DNA was removed using the optional on-column RNase-
free DNase I step (Qiagen, Hilden, Germany). RNA concentra-
tions were determined by reading the OD260 nm, and the RNA was
loaded onto an RNase-free 2% agarose gel to test for generalized
degradation. Equal amounts of RNA were reverse transcribed into
cDNA using the Takara RNA PCR kit (AMV) Ver. 3.0 (Takara,
Kyoto, Japan) according to the manufacturer’s protocol. Genes
names and primer sequences used in the real-time RT-PCR
analysis are listed in Table 4. The real-time RT-PCR was
performed using the 7000 Sequence Detection System (Applied
Biosystems, Courtaboeuf, France) and SYBR Premix Ex Taq
(Takara). Reaction mixtures were initially incubated for 30 s at
95uC, followed by 35 cycles of 5 s at 95uC, 30 s at 55uC, and 20 s
at 72uC. Melt-curve analysis was also performed to assess PCR
specificity, resulting in single primer-specific melting temperatures.
All samples were analyzed in triplicate and the constitutively
expressed gene for gyrase (gyr) was used as an endogenous control
as described previously [32]. In this study, relative quantification
based on the expression of a target gene versus the gyr gene was
utilized to determine the transcript level changes between samples.
Statistical analysis
SPSS 12.0 statistical software was used to analyze experimental
data. The independent Student’s t-test was used to determine
statistical differences, and a p value of less than 0.05 was
considered to be statistically significant.
Supporting Information
Figure S1 Scanning electron micrographs of S. aureus ATCC
29213 after treatment with graded subinhibitory concentrations of
perilla oil to the post-exponential growth phase. (A) perilla oil-free
culture; (B) S. aureuscultured with1/2MIC ofperilla oil; (C) S.aureus
cultured with 1/4 MIC of perilla oil; (D) S. aureus cultured with 1/8
MIC of perilla oil; (E) S. aureus cultured with 1/16MIC of perilla oil.
(TIF)
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Table 4. Primers used for real-time RT-PCR.
Primer Sequence
Location within
gene
gyr-fw 59- AGGTCCTGATTTCCC -39 642–657
gyr-rv 59- GAGCCTTATTCACTTGG -39 814–831
hla -fw 59-TTGGTGCAAATGTTTC-39 485–501
hla-rv 59-TCACTTTCCAGCCTACT-39 569–586
sea-fw 59-ATGGTGCTTATTATGGTTATC-39 335–356
sea-rv 59-CGTTTCCAAAGGTACTGTATT-39 477–498
seb-fw 59-TGTTCGGGTATTTGAAGATGG-39 480–501
seb-rv 59-CGTTTCATAAGGCGAGTTGTT-39 612–633
tst-fw 59-ACCCCTGTTCCCTTATCATC-39 73–93
tst-rv 59-AAAAGCGTCAGACCCACTAC-39 159–180
agrA- fw 59-TGATAATCCTTATGAGGTGCTT-39 111–133
agrA- rv 59-CACTGTGACTCGTAACGAAAA-39 253–274
doi:10.1371/journal.pone.0016160.t004
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